Search

Your search keyword '"Mena de Cea Á"' showing total 23 results

Search Constraints

Start Over You searched for: Author "Mena de Cea Á" Remove constraint Author: "Mena de Cea Á"
23 results on '"Mena de Cea Á"'

Search Results

10. P780 TRENDS IN THE SEROPREVALENCE OF HBV, HCV AND HIV INFECTION AT A REFERENCE MEDICAL AREA IN SPAIN OVER THE LAST FIVE YEARS

11. Analysing Early Diagnosis Strategies for HIV Infection: A Retrospective Study of Missed Diagnostic Opportunities.

12. Renal profile of patients treated with elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide fumarate and dolutegravir/abacavir/lamivudine: 120-week results from a real-world cohort.

13. Metabolic-Related Outcomes After Switching From Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in Adults With Human Immunodeficiency Virus (HIV): A Multicenter Prospective Cohort Study.

14. Discontinuation due to neuropsychiatric adverse events with efavirenz- and dolutegravir-based antiretroviral therapy: a comparative real-life study.

15. Influence of drug-drug interactions on effectiveness and safety of direct-acting antivirals against hepatitis C virus.

16. Effectiveness and safety of direct-acting antivirals in hepatitis C infected patients with mental disorders: Results in real clinical practice.

17. Effectiveness and safety of sofosbuvir/velpatasvir ± ribavirin vs glecaprevir/pibrentasvir in genotype 3 hepatitis C virus infected patients.

18. Deep-sequencing reveals broad subtype-specific HCV resistance mutations associated with treatment failure.

19. Teleconsultation for the Pharmaceutical Care of HIV Outpatients in Receipt of Home Antiretrovirals Delivery: Clinical, Economic, and Patient-Perceived Quality Analysis.

20. Treatment with tenofovir alafenamide fumarate worsens the lipid profile of HIV-infected patients versus treatment with tenofovir disoproxil fumarate, each coformulated with elvitegravir, cobicistat, and emtricitabine.

21. Late HIV Diagnosis but Earlier Antiretroviral Treatment Initiation in Northwest Spain: Impact of Current Treatment Guidelines.

22. Intelligent MONitoring System for antiviral pharmacotherapy in patients with chronic hepatitis C (SiMON-VC).

23. [Ileocolonic invagination in an human immunodeficiency virus-positive man].

Catalog

Books, media, physical & digital resources